Randomized Phase II Trial of Sorafenib, Capecitabine and Oxaliplatin (SECOX) versus Single Agent Sorafenib in Patients with Advanced Hepatocellular Carcinoma


Grant Data
Project Title
Randomized Phase II Trial of Sorafenib, Capecitabine and Oxaliplatin (SECOX) versus Single Agent Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Principal Investigator
Dr Yau, Thomas Chung Cheung   (Principal investigator)
Co-Investigator(s)
Dr Lee Ann Shing   (Co-Investigator)
Dr Cheung Florence   (Co-Investigator)
Professor Poon Ronnie Tung Ping   (Co-Investigator)
Duration
24
Start Date
2015-04-01
Completion Date
2017-03-31
Amount
626806
Conference Title
Presentation Title
Keywords
sorafenib, oxaliplatin, hepatocellular carcinoma, capecitabine
Discipline
Cancer
Panel
Biology and Medicine (M)
Sponsor
RGC General Research Fund (GRF)
HKU Project Code
17125414
Grant Type
General Research Fund (GRF)
Funding Year
2014/2015
Status
On-going